Leverkusen, Germany

Ruth Meissner

This inventor holds 24 USPTO granted patents and 37 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Fungicide Development. Top assignees: Bayer Cropscience Ag, Bayer Intellectual Property Gmbh, Bayer Aktiengesellschaft. Active years: 2004-2022.

USPTO Granted Patents = 24 

% Patents Active = 16.7

 

 

Average Co-Inventor Count = 7.3

ph-index = 3

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2004-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Fungicide
Pyrazole Derivatives
Imidazole Derivatives
Active Compounds
Phenyl Derivatives
Nematicide
Insecticidal
Thiazoles
Bicyclic Compounds
Carboxamides
Chitooligosaccharide
24 patents (USPTO):Explore Patents

Title: Ruth Meissner - Pioneering Female Inventor from Leverkusen

Introduction: Ruth Meissner is a trailblazing inventor hailing from Leverkusen, Germany, known for her groundbreaking contributions to the field of innovation.

Latest Patents: Ruth Meissner holds several patents in the areas of sustainable energy solutions and eco-friendly materials, showcasing her commitment to environmental conservation through technological advancements.

Career Highlights: With a career spanning over two decades, Ruth Meissner has worked tirelessly to develop cutting-edge technologies that have revolutionized various industries, earning her recognition as a leading figure in the world of inventions.

Collaborations: Throughout her career, Ruth Meissner has collaborated with top research institutions, universities, and companies worldwide to bring her innovative ideas to life, fostering a culture of creativity and progress in the field of patent applications.

Conclusion: Ruth Meissner's passion for innovation, coupled with her dedication to creating a more sustainable future, solidifies her legacy as a pioneering female inventor whose work continues to inspire generations of inventors to come.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…